These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4433085)

  • 1. Narcotic withdrawal syndrome caused by naltrexone.
    Tornabene VW
    Ann Intern Med; 1974 Dec; 81(6):785-7. PubMed ID: 4433085
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of EN-1639A (naltrexone): a new narcotic antagonist.
    Resnick RB; Volavka J; Freedman AM; Thomas M
    Am J Psychiatry; 1974 Jun; 131(6):646-50. PubMed ID: 4827793
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of innappropriate naltrexone use in a heroin misuser.
    Boyce SH; Armstrong PA; Stevenson J
    Emerg Med J; 2003 Jul; 20(4):381-2. PubMed ID: 12835366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unintentional rapid opioid detoxification.
    Quigley MA; Boyce SH
    Emerg Med J; 2001 Nov; 18(6):494-5. PubMed ID: 11696513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is naltrexone a cure for heroin dependence?
    Hall WD; Wodak A
    Med J Aust; 1999 Jul; 171(1):9-10. PubMed ID: 10451663
    [No Abstract]   [Full Text] [Related]  

  • 6. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Little M; Murray LM
    Med J Aust; 2008 Oct; 189(8):469; author reply 470-1. PubMed ID: 19024885
    [No Abstract]   [Full Text] [Related]  

  • 7. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Lloyd-Jones DM
    Med J Aust; 2008 Oct; 189(8):468-9; author reply 470-1. PubMed ID: 18928445
    [No Abstract]   [Full Text] [Related]  

  • 8. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Kozminsky MP
    Med J Aust; 2008 Oct; 189(8):469-70; author reply 470-1. PubMed ID: 19031547
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial in post-addicts with oxilorphan (levo-BC-2605): a new narcotic antagonist.
    Tennant FS; Tate JA; Ruckel E
    Drug Alcohol Depend; 1976 Jun; 1(5):329-37. PubMed ID: 13984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Fatality after revivon.
    Vet Rec; 1974 May; 94(20):476-7. PubMed ID: 4852785
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Anaesthesia and Revivon.
    Lakin CN
    Vet Rec; 1974 Jun; 94(23):555-6. PubMed ID: 4428598
    [No Abstract]   [Full Text] [Related]  

  • 12. Caution with naloxone use in asthmatic patients.
    Allegretti PJ; Bzdusek JS; Leonard J
    Am J Emerg Med; 2006 Jul; 24(4):515-6. PubMed ID: 16787825
    [No Abstract]   [Full Text] [Related]  

  • 13. Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
    Lescut C; Gaboriau L; Carton L; Rolland B
    J Clin Psychopharmacol; 2017 Oct; 37(5):631-633. PubMed ID: 28806388
    [No Abstract]   [Full Text] [Related]  

  • 14. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal syndrome caused by naltrexone in opioid abusers.
    Hassanian-Moghaddam H; Afzali S; Pooya A
    Hum Exp Toxicol; 2014 Jun; 33(6):561-7. PubMed ID: 23690227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Brewer CL
    Med J Aust; 2008 Oct; 189(8):470; author reply 470-1. PubMed ID: 19024886
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in withdrawal from opiates.
    Hollister LE; Prusmack JJ
    Arch Gen Psychiatry; 1974 Nov; 31(5):695-8. PubMed ID: 4441241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.